Can psilocybin from mushrooms reduce depression symptoms in people with cancer?

Psilocybin-assisted therapy has been studied for treatment-resistant depression and cancer-related psychological distress. In this episode, we examine what current clinical trials show and how this topic is regulated in Europe.

In this episode, we cover:

• What psilocybin is (a psychedelic compound found in certain mushrooms)

• How it may affect serotonin receptors and mood pathways

• Research on psilocybin-assisted psychotherapy in cancer patients

• Reported effects on depression, anxiety, and end-of-life distress

• Safety considerations and psychological screening requirements

• Legal status of psilocybin across European countries

• Why unsupervised use carries medical and psychiatric risks